CRIS Current Research Information System

GIANNELLA, MADDALENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.088
NA - Nord America 12.001
EU - Europa 10.303
SA - Sud America 880
AF - Africa 635
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 7
Totale 37.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.777
SG - Singapore 4.002
CN - Cina 3.797
IT - Italia 3.715
VN - Vietnam 3.171
GB - Regno Unito 1.721
DE - Germania 957
SE - Svezia 946
HK - Hong Kong 860
FR - Francia 594
IN - India 589
BR - Brasile 576
KR - Corea 575
NL - Olanda 445
RU - Federazione Russa 443
IE - Irlanda 314
JP - Giappone 294
FI - Finlandia 242
CI - Costa d'Avorio 225
ZA - Sudafrica 158
AR - Argentina 133
BG - Bulgaria 126
CA - Canada 118
UA - Ucraina 115
AT - Austria 109
ID - Indonesia 104
EE - Estonia 96
CH - Svizzera 94
ES - Italia 83
BD - Bangladesh 81
PH - Filippine 76
JO - Giordania 71
IQ - Iraq 68
PL - Polonia 68
TG - Togo 64
BE - Belgio 63
TH - Thailandia 63
TR - Turchia 62
MX - Messico 59
AU - Australia 53
NG - Nigeria 42
TW - Taiwan 42
SA - Arabia Saudita 40
SC - Seychelles 38
PK - Pakistan 36
PE - Perù 35
CL - Cile 32
EC - Ecuador 31
MY - Malesia 28
CO - Colombia 26
RO - Romania 26
EG - Egitto 25
UZ - Uzbekistan 23
GR - Grecia 21
IR - Iran 21
PY - Paraguay 20
LT - Lituania 19
HR - Croazia 16
VE - Venezuela 16
MA - Marocco 15
PT - Portogallo 15
AE - Emirati Arabi Uniti 14
KE - Kenya 13
AZ - Azerbaigian 12
DZ - Algeria 12
RS - Serbia 11
DK - Danimarca 10
AL - Albania 9
JM - Giamaica 9
TN - Tunisia 9
DO - Repubblica Dominicana 7
LB - Libano 7
LY - Libia 7
PA - Panama 7
HN - Honduras 6
HU - Ungheria 6
IL - Israele 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
NP - Nepal 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
BH - Bahrain 4
CR - Costa Rica 4
ET - Etiopia 4
FJ - Figi 4
KG - Kirghizistan 4
MD - Moldavia 4
MK - Macedonia 4
MM - Myanmar 4
NI - Nicaragua 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
Totale 37.913
Salva come PNG Salva come JPEG
Città #
Singapore 2.813
Ashburn 1.506
Southend 1.450
Hefei 1.226
Fairfield 1.015
Hong Kong 795
Chandler 774
Ho Chi Minh City 767
San Jose 760
Hanoi 673
Bologna 587
Seoul 527
Santa Clara 502
Woodbridge 474
Wilmington 439
Seattle 426
Houston 402
Beijing 368
Cambridge 360
Princeton 320
Ann Arbor 315
Dublin 311
Boardman 294
Milan 273
Tokyo 256
Rome 241
Dallas 236
New York 228
Abidjan 225
Lauterbourg 218
Los Angeles 214
Dong Ket 204
Council Bluffs 181
Helsinki 159
Bengaluru 127
Sofia 121
Berlin 117
Westminster 112
Nanjing 108
Da Nang 107
Redondo Beach 104
Padova 99
Frankfurt am Main 93
Turin 93
Buffalo 92
Haiphong 87
Munich 85
Chicago 83
Florence 83
São Paulo 78
Shanghai 77
Saint Petersburg 75
Amman 69
Jakarta 69
Bern 67
Guangzhou 66
Lomé 64
Redmond 61
San Diego 61
Vienna 61
Falls Church 59
Jinan 59
Lappeenranta 58
Naples 58
Shenyang 58
Amsterdam 57
Nuremberg 57
Bremen 53
Brussels 52
Warsaw 50
London 47
Modena 45
The Dalles 43
Castel Maggiore 40
Toronto 40
Genoa 39
Hải Dương 39
Hebei 38
Johannesburg 38
Can Tho 36
Nanchang 36
Paris 36
Changsha 35
Dearborn 35
Des Moines 35
Montreal 35
Verona 35
Biên Hòa 34
Tongling 34
Abeokuta 33
Baghdad 33
Orem 33
Redwood City 33
San Francisco 32
Phoenix 31
Falkenstein 30
Palermo 30
Reggio Emilia 30
Olalla 29
Denver 28
Totale 23.421
Salva come PNG Salva come JPEG
Nome #
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 955
Caratterizzazione fenotipica e genotipica di ceppi di Staphylococcus aureus isolati in corso di batteriemia 786
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 559
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 322
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 322
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 314
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 268
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 253
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 253
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 252
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 250
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 249
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 246
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 238
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 238
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 235
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 227
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 225
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 219
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 217
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 213
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 212
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 209
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 197
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 197
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 196
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 194
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 193
Invasive candidiasis due to candida norvegensis in a liver transplant patient: Case report and literature review 193
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 193
Advances in the therapy of bacterial bloodstream infections 191
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 190
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 190
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 190
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 189
Impact of preoperative infection on outcome after liver transplantation 188
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 186
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 185
Bloodstream infections in patients with liver cirrhosis 185
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery 184
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 183
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 183
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 182
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 182
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 181
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 181
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 179
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 178
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 177
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 176
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 172
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 172
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 172
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 172
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 172
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study 169
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 168
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 167
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 166
Diffuse primary cutaneous infection by Alternaria alternata in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution 165
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 164
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 164
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 162
Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program 162
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 162
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 162
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 161
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 160
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 158
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 158
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 158
Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis 157
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 157
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 157
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 157
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 157
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 156
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 155
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 155
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 154
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 153
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 153
The Gut Microbiota of Critically Ill Patients With COVID-19 153
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 151
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 151
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 151
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 151
LA CONTAMINAZIONE DEL LIQUIDO DI PERFUSIONE DELL’ORGANO NEL TRAPIANTO DI FEGATO:INCIDENZA, PROFILO MICROBIOLOGICO ED IMPATTO CLINICO. 150
Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients 150
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 149
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 148
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2 147
CMV-RNAemia as new marker of active viral replication in transplant recipients 147
Candida tropicalis fungaemia: Incidence, risk factors and mortality in a general hospital 146
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 146
Pneumonia treated in the internal medicine department: Focus on healthcare-associated pneumonia 145
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 144
Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae 144
Totale 20.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021989 0 0 0 0 0 0 0 0 0 173 141 675
2021/20223.310 228 100 160 269 272 208 124 270 170 379 540 590
2022/20233.795 336 412 201 496 356 303 141 255 683 173 233 206
2023/20242.053 148 243 154 189 170 322 157 138 92 165 125 150
2024/20256.982 241 759 535 566 796 385 545 301 236 559 744 1.315
2025/202615.880 1.600 2.035 1.663 1.403 1.613 870 1.950 594 3.169 983 0 0
Totale 38.865